Developmental Stages and Clinical Conditions for Vascular Access in Pediatrics

Vessel Health and Preservation: The Right Approach for Vascular Access

Volumn , Issue , 2019, Pages 171-179

  Ullman, Amanda ^a   Kleidon, Tricia ^b  

^a Nursing Midwifery Office   (Australia)

^b QUEENSLAND CHILDREN S HOSPITAL   (Australia)

Author keywords

Pediatric developmental stages; VHP for adolescents

Indexed keywords

EID: 85151644660     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-030-03149-7_13     Document Type: Chapter

References (27)

1. Abu–Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology. 2006;130:S132–7. https://doi.org/10.1053/j.gastro.2005.09.069.
2. August DL, New K, Ray RA, Kandasamy Y. Frequency, location and risk factors of neonatal skin injuries from mechanical forces of pressure, friction, shear and stripping: a systematic literature review. J Neonatal Nurs. 2017;24(4):173–80. https://doi.org/10.1016/j.jnn.2017.08.003.
3. Barone A, Lucarelli A, Onofrillo D, Verzegnassi F, Bonanomi S, Cesaro S, Fioredda F, Iori AP, Ladogana S, Locasciulli A, Longoni D, Lanciotti M, Macaluso A, Mandaglio R, Marra N, Martire B, Maruzzi M, Menna G, Notarangelo LD, Palazzi G, Pillon M, Ramenghi U, Russo G, Svahn J, Timeus F, Tucci F, Cugno C, Zecca M, Farruggia P, Dufour C, Saracco P. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Blood Cell Mol Dis. 2015;55:40–7. https://doi.org/10.1016/j.bcmd.2015.03.007.
4. Bhatnagar N, Samarasinghe S. Diagnosis and management of childhood aplastic anaemia. Paediatr Child Health. 2015;25:343–9. https://doi.org/10.1016/j.paed.2015.04.001.
5. Chang RW, Javid PJ, Oh J-T, Andreoli S, Kim HB, Fauza D, Jaksic T. Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome. Ann Surg. 2006;243:223. https://doi.org/10.1097/01.sla.0000197704.76166.07.
6. Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med. 2010;182:298–306. https://doi.org/10.1164/rccm.201002-0157CI.
7. Franck L, Hummel D, Connell K, Quinn D, Montgomery J. The safety and efficacy of peripheral intravenous catheters in ill neonates. Neonatal Netw. 2001;20:33– 8. https://doi.org/10.1891/0730-0832.20.5.33.
8. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943–55. https://doi.org/10.1016/S0140-6736(12)62187-4.
9. Lister T, Crowther D, Sutcliffe S, Glatstein E, Canellos G, Young R, Rosenberg S, Coltman C, Tubiana M. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: cotswolds meeting. J Clin Oncol. 1989;7:1630–6. https://doi.org/10.1200/JCO.1989.7.11.1630.
10. Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D. Pediatric hodgkin lymphoma. J Clin Oncol. 2015;33:2975–85. https://doi.org/10.1200/JCO.2014.59.4853.
11. Mccullen KL, Pieper B. A retrospective chart review of risk factors for extravasation among neonates receiving peripheral intravascular fluids. J Wound Ostomy Cont Nurs. 2006;33:133–9. https://doi.org/10.1097/00152192-200603000-00006.
12. Murag S, Suzukawa C, Chang TP. The effects of child life specialists on success rates of intravenous cannulation. J Pediatr Nurs. 2017;36:236–40. https://doi.org/10.1016/j.pedn.2017.03.013.
13. Nightingale J, Woodward JM. Guidelines for management of patients with a short bowel. Gut. 2006;55:iv1–iv12. https://doi.org/10.1136/gut.2006.091108.
14. Pedersen MG, Jensen-Fangel S, Olesen HV, Tambe SDP, Petersen E. Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis. BMC Infect Dis. 2015;15:290. https://doi.org/10.1186/s12879-015-1019-4.
15. Pittiruti M, Hamilton H, Biffi R, Macfie J, Pertkiewicz M. ESPEN Guidelines on parenteral nutrition: central venous catheters (Access, Care, Diagnosis and Therapy of Complications). Clin Nutr. 2009;28:365– 77. https://doi.org/10.1016/j.clnu.2009.03.015.
16. Ponnusamy V, Venkatesh V, Clarke P. Skin antisepsis in the neonate: what should we use? Curr Opin Infect Dis. 2014;27:244–50. https://doi.org/10.1097/QCO.0000000000000064.
17. Rudolf M, Lee T, Levene M, editors. Paediatrics and child health. Chichester: Wiley; 2011.
18. Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, Sermet-Gaudelus I, Southern KW, Taccetti G, Ullrich G, Wolfe S. European cystic fibrosis society standards of care: best practice guidelines. J Cyst Fibros. 2014;13(Suppl 1):S23–42. https://doi.org/10.1016/j.jcf.2014.03.010.
19. Sorge C, Mcdaniel J, Xavier A. Targeted therapies for the treatment of pediatric non-hodgkin lymphomas: present and future. Pharmaceuticals. 2016;9:28. https://doi.org/10.3390/ph9020028.
20. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A, Treatment Guidelines Working Group the World Federation of Hemophilia. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–e47. https://doi.org/10.1111/j.1365-2516.2012.02909.x.
21. Tarlock K, Meshinchi S. Pediatric acute myeloid leukemia. Pediatr Clinics North Am. 2015;62:75–93. https://doi.org/10.1016/j.pcl.2014.09.007.
22. Tobias JD, Ross AK. Intraosseous infusions: a review for the anesthesiologist with a focus on pediatric use. Anesth Analg. 2010;110:391–401. https://doi.org/10.1213/ANE.0b013e3181c03c7f.
23. Ullman AJ, Keogh S, Coyer F, Long DA, New K, Rickard CM. ‘True Blood’ The Critical Care Story: an audit of blood sampling practice across three adult, paediatric and neonatal intensive care settings. Aust Crit Care. 2016;29(2):90–5. https://doi.org/10.1016/j.aucc.2015.06.002.
24. Visscher MO, Burkes SA, Adams DM, Hammill AM, Wickett RR. Infant skin maturation: preliminary outcomes for color and biomechanical properties. Skin Res Technol. 2017;23(4):545–51. https://doi.org/10.1111/srt.12369.
25. Ware RE, De Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017;390:311–23. https://doi.org/10.1016/S0140-6736(17)30193-9.
26. World Health Organisation. Genes and human disease [Online]. 2012. Accessed 31 Aug 2017.
27. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033–48.https://doi.org/10.1001/jama.2014.10517